M
MaxCyte Inc
NASDAQ:MXCT
MaxCyte Inc
NASDAQ:MXCT
Price:
0.7914
USD
4.13%
Market Closed
Market Cap:
$84.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
MaxCyte Inc
NASDAQ:MXCT
|
US |
|
A
|
Asefa PCL
SET:ASEFA
|
TH |
|
T
|
Taier Heavy Industry Co Ltd
SZSE:002347
|
CN |
|
Chicago Atlantic BDC Inc
NASDAQ:LIEN
|
US |
|
Asia Pile Holdings Corp
TSE:5288
|
JP |
|
D
|
discoverIE Group plc
LSE:DSCV
|
UK |
|
HKC International Holdings Ltd
HKEX:248
|
HK |
|
G
|
Guardian Capital Group Ltd
TSX:GCG.A
|
CA |
|
L
|
Logan Group Co Ltd
HKEX:3380
|
CN |
|
I
|
Inbest Prime VII Inmuebles SOCIMI SA
MAD:YINB7
|
ES |
|
Prakash Industries Ltd
NSE:PRAKASH
|
IN |
|
Power Grid Corporation of India Ltd
NSE:POWERGRID
|
IN |
Income Statement
Earnings Waterfall
MaxCyte Inc
MaxCyte Inc
Income Statement
MaxCyte Inc
MaxCyte Inc
Currency: USD
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
39
N/A
|
41
+6%
|
42
+1%
|
44
+5%
|
41
-7%
|
41
-1%
|
38
-6%
|
41
+9%
|
44
+7%
|
45
+3%
|
46
+0%
|
39
-15%
|
38
-2%
|
36
-5%
|
34
-4%
|
33
-4%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(6)
|
|
| Gross Profit |
35
N/A
|
37
+6%
|
37
+0%
|
39
+5%
|
36
-8%
|
35
-2%
|
33
-6%
|
37
+10%
|
39
+6%
|
40
+3%
|
39
-2%
|
32
-20%
|
30
-3%
|
29
-6%
|
28
-4%
|
27
-3%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(51)
|
(57)
|
(63)
|
(67)
|
(73)
|
(76)
|
(80)
|
(85)
|
(86)
|
(86)
|
(86)
|
(83)
|
(81)
|
(82)
|
(77)
|
(71)
|
|
| Selling, General & Administrative |
(36)
|
(41)
|
(43)
|
(44)
|
(48)
|
(50)
|
(53)
|
(57)
|
(58)
|
(58)
|
(58)
|
(56)
|
(55)
|
(55)
|
(51)
|
(46)
|
|
| Research & Development |
(13)
|
(15)
|
(17)
|
(20)
|
(22)
|
(23)
|
(24)
|
(24)
|
(24)
|
(24)
|
(23)
|
(22)
|
(21)
|
(22)
|
(22)
|
(21)
|
|
| Depreciation & Amortization |
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
|
| Operating Income |
(16)
N/A
|
(20)
-27%
|
(26)
-26%
|
(27)
-7%
|
(36)
-33%
|
(41)
-12%
|
(47)
-15%
|
(48)
-3%
|
(47)
+2%
|
(46)
+2%
|
(46)
0%
|
(51)
-10%
|
(50)
+2%
|
(53)
-6%
|
(50)
+7%
|
(45)
+11%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
(0)
|
0
|
2
|
4
|
6
|
8
|
10
|
10
|
11
|
11
|
11
|
10
|
9
|
9
|
8
|
7
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
(4)
|
(7)
|
|
| Pre-Tax Income |
(16)
N/A
|
(20)
-24%
|
(24)
-19%
|
(24)
+0%
|
(30)
-29%
|
(33)
-7%
|
(37)
-15%
|
(38)
-1%
|
(37)
+4%
|
(35)
+3%
|
(36)
-1%
|
(41)
-15%
|
(42)
-2%
|
(45)
-7%
|
(46)
-2%
|
(45)
+2%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(16)
|
(20)
|
(24)
|
(24)
|
(30)
|
(33)
|
(37)
|
(38)
|
(37)
|
(35)
|
(36)
|
(41)
|
(42)
|
(45)
|
(46)
|
(45)
|
|
| Net Income (Common) |
(16)
N/A
|
(20)
-24%
|
(24)
-19%
|
(24)
+0%
|
(30)
-29%
|
(33)
-7%
|
(37)
-15%
|
(38)
-1%
|
(37)
+4%
|
(35)
+3%
|
(36)
-1%
|
(41)
-15%
|
(42)
-2%
|
(45)
-7%
|
(46)
-2%
|
(45)
+2%
|
|
| EPS (Diluted) |
-0.17
N/A
|
-0.2
-18%
|
-0.23
-15%
|
-0.23
N/A
|
-0.3
-30%
|
-0.32
-7%
|
-0.37
-16%
|
-0.37
N/A
|
-0.35
+5%
|
-0.34
+3%
|
-0.34
N/A
|
-0.39
-15%
|
-0.4
-3%
|
-0.42
-5%
|
-0.43
-2%
|
-0.42
+2%
|
|
Switch to:
Switch to:
See Also
Discover More
